RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
25 hedge funds and large institutions have $15M invested in Regulus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Holders
25
Holding in Top 10
–
Calls
$535K
Puts
–
Top Buyers
| 1 | +$988K | |
| 2 | +$36K | |
| 3 | +$16.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.7K |
| 5 |
Renaissance Technologies
New York
|
+$5.51K |
Top Sellers
| 1 | -$27.2K | |
| 2 | -$22.2K | |
| 3 | -$5.81K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.38K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$548 |